Gefitinib Gefticip 250mg Tablet

Get a Price/Quote

MOQ : 100 Packs

Gefitinib Gefticip 250mg Tablet Specification

Salt Composition
Gefitinib 250mg

Dosage Form
Tablet

Indication
Non-Small Cell Lung Cancer (NSCLC)

Feature
Oral targeted therapy for cancer

Application
Cancer Therapy

Physical Color/Texture
Tablet Color: Not specified

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 Months

Administration Route
Oral

Brand Name
Gefticip

Marketed In
Available internationally (e.g., Canada, Europe, UK, US, Australia as shown)

Therapeutic Class
Antineoplastic (Anti-Cancer)

Prescription Required
Yes

Packaging Type
Box

Pack Size
30 Tablets per box

Strength
250 mg per tablet

Gefitinib Gefticip 250mg Tablet Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Gefitinib Gefticip 250mg Tablet

Experience the sensational potency of Gefitinib Gefticip 250mg Tablet, a paragon in targeted anti-cancer therapy now available at the lowest reduced price. This trending medication is tailored for Non-Small Cell Lung Cancer (NSCLC) treatment, delivering ravishing results through its advanced oral formulation. Each box contains 30 tablets, with every unit containing 250mg of Gefitinib, manufactured to superior standards in India. Prescription required. With international reach across Canada, Europe, UK, US, and Australia, Gefticip guarantees quality, efficacy, and peace of mind for patients and healthcare providers. Store below 30C to maintain its shelf life of 24 months.

Advanced Cancer Therapy: Usage & Key Features

Gefitinib Gefticip 250mg Tablets are designed for the oral management of Non-Small Cell Lung Cancer (NSCLC) in adults. This therapy's usage type is strictly on prescription, making it suitable for hospital, oncology clinics, and specialty pharmacies. Key features include its targeted oral delivery, ease of administration, international registration, and the convenience of a box pack of 30. The product's application in various clinical settings ensures comprehensive cancer care backed by consistent, high-strength dosing.

Delivery, Exports, and Seamless Supply Network

Gefitinib Gefticip 250mg Tablet supply is streamlined for rapid dispatch and exchange both in the domestic market and for international delivery. The product is exported to primary markets like Canada, Europe, the UK, US, and Australia, with prompt arrival times based on regional logistics. Manufacturers ensure excellent supply ability, supporting bulk orders for traders and healthcare providers, while consistent supply chains guarantee timely fulfillment and high standards globally.

FAQ's of Gefitinib Gefticip 250mg Tablet:

Q: How should Gefitinib Gefticip 250mg Tablet be administered?

A: Gefitinib Gefticip 250mg Tablet is taken orally, typically once daily, as directed by your healthcare provider. It should be swallowed whole with water, with or without food.

Q: What are the benefits of using Gefitinib Gefticip for NSCLC?

A: Gefitinib Gefticip is a targeted therapy specifically designed to inhibit cancer growth pathways in Non-Small Cell Lung Cancer, offering improved outcomes for eligible patients through convenient oral dosing.

Q: Where is Gefitinib Gefticip 250mg Tablet available?

A: Gefticip is available internationally, including major markets such as Canada, Europe, the UK, US, and Australia, and is distributed by manufacturers, suppliers, and traders from India.

Q: When can I expect my order of Gefitinib Gefticip to arrive?

A: Delivery time depends on your location and order size, with prompt dispatch ensured for both domestic and international exchanges. Arrival is typically within a few business days, subject to customs clearance.